Reverse Stock Split. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market that the Company is failing to satisfy the Trading Market’s minimum bid price requirement (the “Trigger Date”), then the Company shall take all necessary steps to obtain the necessary consents and approvals to undertake a reverse stock split after such Trigger Date and shall, prior to the effectiveness of any delisting notice issued by the Trading Market, effect such reverse stock split.
Appears in 11 contracts
Sources: Common Stock Purchase Warrant (PMGC Holdings Inc.), Common Stock Purchase Warrant (PMGC Holdings Inc.), Series a Common Stock Purchase Warrant (Hepion Pharmaceuticals, Inc.)
Reverse Stock Split. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market Nasdaq Listing Qualifications Department that the Company is failing to satisfy the Trading Market’s $1.00 minimum bid price requirement (the “Trigger Date”), then the Company shall take all necessary steps to obtain the necessary consents and approvals to undertake a reverse stock split after such Trigger Date and shall, prior to the effectiveness of any delisting notice issued by the Trading Nasdaq Capital Market, effect such reverse stock split.
Appears in 8 contracts
Sources: Warrant Agreement (ENDRA Life Sciences Inc.), Warrant Agreement (ENDRA Life Sciences Inc.), Warrant Agreement (Applied Dna Sciences Inc)
Reverse Stock Split. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market Nasdaq Listing Qualifications Department that the Company is failing to satisfy the Trading Market’s $1.00 minimum bid price requirement (the “Trigger Date”), then the Company shall take all necessary steps to obtain the necessary consents and approvals to undertake a reverse stock split after such Trigger Date and shall, prior to the effectiveness of any delisting notice issued by the Trading MarketNasdaq, effect such reverse stock split.
Appears in 2 contracts
Sources: Warrant Agreement (Applied Dna Sciences Inc), Warrant Agreement (Applied Dna Sciences Inc)
Reverse Stock Split. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market that the Company is failing to satisfy the Trading Market’s minimum bid price requirement (the “Trigger Date”), then the Company shall take all necessary steps use reasonable efforts to obtain the necessary consents and approvals to undertake a reverse stock split after such Trigger Date and shall, prior to the effectiveness of any delisting notice issued by the Trading Market, effect such reverse stock split.
Appears in 2 contracts
Sources: Warrant Agreement (Algorhythm Holdings, Inc.), Warrant Agreement (Algorhythm Holdings, Inc.)
Reverse Stock Split. If at any time this Warrant is outstanding and the Company receives notice from the Trading Market that the Company is failing to satisfy the Trading Market’s minimum bid price requirement (the “Trigger Date”), then the Company shall take all necessary steps use reasonable efforts to obtain the necessary consents and approvals to undertake a reverse stock split after such Trigger Date and shall, to prior to the effectiveness of any delisting notice issued by the Trading Market, effect such reverse stock split.
Appears in 1 contract
Sources: Series a Common Stock Purchase Warrant (Algorhythm Holdings, Inc.)